Skip to content

CUCURBITACEAE FAMILY MEDICINES WILL BE GIVEN TO PATIENTS ACCORDING TO RUBRICS SELECTED FROM KENTS REPERTORY AND ACCORDINGLY POTENCIES WILL BE SELECTED AND GIVEN.

TO EXTRACT RUBRICS CONTAINING MEDICINES OF CUCURBITACEAE FAMILY FROM REPERTORY OF HOMOEOPATHIC MATERIA MEDICA BY DR. J. T . KENT AND CLINICAL VERIFICATION OF THESE RUBRICS - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065622
Enrollment
30
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R69- Illness, unspecified

Interventions

Intervention1: BRYONIA, COLOCYNTH, ELATERIUM, CORIARIA R.: 6,30,200,1M,10M Intervention2: Homoeopathic Remedy - BRYONIA, COLOCYNTH, ELATERIUM, CORIARIA R.: Medicine will be given in different potencie

Sponsors

DR VANI RATHOD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The cases where medicines from Cucurbitaceae family will be indicated. 2. Cases of all races and religion will be indicated. 3. Caes of all socioeconomic conditions will be included. 4. Cases having chief complaint of nervous system, locomotor system, digestive system.

Exclusion criteria

Exclusion criteria: 1. Cases with severe systemic pathology will be excluded. 2. Cases with irreversible pathology will be excluded from the study. 3. Female cases those are having pregnancy will be excluded.

Design outcomes

Primary

MeasureTime frame
MEASURE YOURSELF MEDICAL OUTCOME PROFILETimepoint: Every 1, 2 or 3 Weeks or as per requirement of the case and at the end of treatment.

Secondary

MeasureTime frame
Not applicableTimepoint: NIL

Countries

India

Contacts

Public ContactDR VANI RATHOD

DR. V. H. DAVE HOMOEOAPTHIC MEDICAL COLLEGE, AMUL DAIRY ROAD, ANAND.

dr.meerashah@yahoo.com9898692003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026